Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Drug Target ; 13(4): 235-43, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-16051535

RESUMO

Successful application of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) has been attracting worldwide interest, but the exact mechanism for the action of As2O3 remains somewhat obscure. In the present work, we show for the first time that As2O3 facilitates the DIDS-sensitive anion transport activity of band 3 protein in red blood cells (RBCs) isolated from normal adults and APL patients. To elucidate the effect of As2O3 on band 3 protein, constructs encoding the full length of the band 3 transmembrane domain (mdb3) and its C-terminal deletion forms were transfected into yeast cells by a yeast display system. The results demonstrate that deletion of the C-terminal 16 residues of mdb3 (mdb3-d16) does not affect anion transport activity of mdb3 or its sensitivity to DIDS, but decreases its sensitivity to As2O3 in the yeast cell. More intriguingly, the forced expression of intact mdb3 by transfection significantly induces cell apoptosis in HeLa cells, to a higher degree than in cells transfected with mdb3-d16 or empty vector. Expression of activated caspase 3 in HeLa cells also indicates that the C-terminal 16 residues are important for mdb3-mediated apoptosis in cells treated with As2O3. Our results provide the first evidence that As2O3 enhances the anion transport activity of band 3 and the action is related with the C-terminal 16 residues of the protein.


Assuntos
Proteína 1 de Troca de Ânion do Eritrócito/metabolismo , Antineoplásicos/uso terapêutico , Apoptose/efeitos dos fármacos , Arsenicais/uso terapêutico , Eritrócitos/efeitos dos fármacos , Leucemia Promielocítica Aguda/tratamento farmacológico , Óxidos/uso terapêutico , Ácido 4,4'-Di-Isotiocianoestilbeno-2,2'-Dissulfônico/farmacologia , Adulto , Proteína 1 de Troca de Ânion do Eritrócito/genética , Antineoplásicos/farmacologia , Trióxido de Arsênio , Arsenicais/farmacologia , Eritrócitos/metabolismo , Feminino , Deleção de Genes , Células HeLa , Humanos , Técnicas In Vitro , Leucemia Promielocítica Aguda/sangue , Masculino , Óxidos/farmacologia , Transfecção , Leveduras/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA